Clobetasol Propionate (CAS 25122-46-7) is a high-potency, pharmaceutical-grade corticosteroid synthesized with advanced chiral synthesis technology, ensuring ultra-high purity and compliance with USP, EP, and CP standards. Its molecular structure is optimized for enhanced topical penetration, allowing rapid absorption through the stratum corneum to target inflammatory sites directly. Produced with strict quality control measures, each batch undergoes rigorous impurity testing, guaranteeing consistent efficacy and minimal side effects, making it a gold-standard raw material for dermatological drug formulation.
This super-potent corticosteroid exhibits exceptional anti-inflammatory, anti-allergic, and anti-pruritic properties, effectively alleviating symptoms of severe skin conditions such as psoriasis, eczema, and lichen planus. Unlike moderate-strength steroids, it delivers fast-acting relief from redness, swelling, and itching, while its targeted mechanism reduces systemic absorption risk. It is also highly valued for its anti-proliferative effects, which help normalize abnormal skin cell growth in chronic dermatological disorders.
Clobetasol Propionate (CAS 25122-46-7) caters to diverse professional needs, from pharmaceutical manufacturers developing topical creams, ointments, and lotions to research institutions conducting dermatology-related studies. Its high potency, reliable quality, and proven clinical efficacy make it a top choice for buyers prioritizing performance and safety. Whether for large-scale production of prescription dermatological drugs or small-batch scientific experiments, this corticosteroid meets the stringent requirements of the global pharmaceutical industry.
